Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Biosensia Ltd.
Irish Biotech Opsona Adds Two New Corporate VCs In $43M Series C
Irish biotech Opsona Therapeutics recently raised $43 million with the help of four corporate VCs, for use in developing its potential first-in-class product for preventing delayed graft function in high-risk renal transplant patients.
Recent Financings of Private Companies (12/2011)
Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research/analytical instrumentation and reagent sectors.
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
- In Vitro Diagnostics
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.